|
ZNF721 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.38909994618075E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.95240000225405E-08 |
| Normal-vs-Stage2 |
8.31850000000411E-05 |
| Normal-vs-Stage3 |
2.28459999807029E-08 |
| Normal-vs-Stage4 |
1.03399999995535E-06 |
| Stage1-vs-Stage2 |
7.468000E-01 |
| Stage1-vs-Stage3 |
1.764230E-01 |
| Stage1-vs-Stage4 |
4.454000E-01 |
| Stage2-vs-Stage3 |
5.629600E-01 |
| Stage2-vs-Stage4 |
7.552800E-01 |
| Stage3-vs-Stage4 |
7.920400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.84170001471529E-09 |
| Normal-vs-AfricanAmerican |
1.777790E-02 |
| Normal-vs-Asian |
7.59490000000751E-05 |
| Caucasian-vs-AfricanAmerican |
2.198800E-01 |
| Caucasian-vs-Asian |
5.858200E-01 |
| AfricanAmerican-vs-Asian |
4.707000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.10250000018297E-07 |
| Normal-vs-Female |
5.02899999421658E-09 |
| Male-vs-Female |
8.774200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.7919999997309E-08 |
| Normal-vs-Age(41-60Yrs) |
7.54169999783727E-08 |
| Normal-vs-Age(61-80Yrs) |
4.65780000014071E-07 |
| Normal-vs-Age(81-100Yrs) |
4.244500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.277800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.349600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.055400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.394200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.839800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.395000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.941230E-03 |
| Classical-VS-Follicular |
5.960600E-03 |
| Classical-VS-Other |
3.827600E-01 |
| Classical-VS-Normal |
8.75629999952388E-07 |
| Tall-VS-Follicular |
4.875400E-01 |
| Tall-VS-Other |
6.747800E-01 |
| Tall-VS-Normal |
3.17570000296641E-08 |
| Follicular-VS-Other |
9.625000E-01 |
| Follicular-VS-Normal |
2.72750000362976E-08 |
| Other-VS-Normal |
1.808190E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.54689999487934E-08 |
| Normal-vs-N1 |
1.67900000003218E-06 |
| N0-vs-N1 |
7.198400E-01 |
|
|
